Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells

Growth Factors

Volumn 24, Issue 2, 2006, Pages 151-157

  Lund, Leifvik ^a   Rontsova, Nataliavo ^a   Henttinen, Tiina ^a   Salmivirta, Markku ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Cancer; Cell proliferation; Erk phosphorylation; Fibroblast growth factor; Syndecan 1

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOGLYCAN; SDC1 PROTEIN, MOUSE; SYNDECAN; SYNDECAN 1; TESTOSTERONE;

ANIMAL; ARTICLE; CARCINOMA; EXPERIMENTAL NEOPLASM; GENE EXPRESSION; GENETIC TRANSFORMATION; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 8; GENE EXPRESSION; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; PROTEOGLYCANS; SYNDECAN-1; SYNDECANS; TESTOSTERONE; TRANSFORMATION, GENETIC;

EID: 33750630620     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190600699426     Document Type: Article

References (34)

1. Anttonen A, Heikkila P, Kajanti M, Jalkanen M, Joensuu H. 2001 High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer 32:297-305 (Pubitemid 32487690)
2. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. 1994. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 269:114-121 (Pubitemid 24026631)
3. Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C. 2003. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 98:474-483 (Pubitemid 36885986)
4. Bayer-Garner IB, Dilday B, Sanderson RD, Smoller BR. 2000 Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma. Am J Dermatopathol 22:119-122 (Pubitemid 30185832)
5. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777 (Pubitemid 29449208)
6. Borgenstrom M, Tienhaara A, Spillmann D, Salmivirta M, Jalkanen M. 2001. Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate. Exp Cell Res 264:307-314 (Pubitemid 32980235)
7. Borgenstrom M, Jalkanen M, Salmivirta M. 2003. Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling. J Biol Chem 278:49882-49889 (Pubitemid 37548823)
8. Carey DJ. 1997. Syndecans: Multifunctional cell-surface co-receptors. Biochem J 327:1-16 (Pubitemid 27455453)
9. Fujiya M,Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y. 2001. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res 92:1074-1081 (Pubitemid 33041176)
10. Harada K, Masuda S, Hirano M, Nakanuma Y. 2003. Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma. Hum Pathol 34:857-863 (Pubitemid 37169614)
11. Inki P, Stenback F, Talve L, Jalkanen M. 1991. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 139:1333-1340
12. Inki P, Gomez M, Quintanilla M, Cano A, Jalkanen M. 1992a. Expression of syndecan in transformed mouse keratinocytes. Lab Invest 67:225-233
13. Inki P, Kujari H, Jalkanen M. 1992b. Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab Invest 66:314-323
14. Jalkanen M, Rapraeger A, Saunders S, Bernfield M. 1987. Cell surface proteoglycan of mammary epithelial cells is shed by cleavage of of its matrix-binding ectodomain from its membraneassociated domain. J Cell Biol 105:3087-3096 (Pubitemid 18043883)
15. Kokel M, Borland CZ, DeLong L, Horvitz HR, Stern MJ. 1998 clr-1 encodes a receptor tyrosine phosphatase that negatively regulates an FGF receptor signaling pathway in Caenorhabditis elegans. Genes Dev 12:1425-1437 (Pubitemid 28243628)
16. Leppä S, Härkönen P, Jalkanen M. 1991. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regul 2:1-11
17. Leppä S, Mali M, Miettinen HM, Jalkanen M. 1992. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci USA 89:932-936
18. Lu J, Nishizawa Y, Tanaka A, Nonomura N, Yamanishi H, Uchida N, Sato B, Matsumoto K. 1989. Inhibitory effect of antibody against basic fibroblast growth factor on androgen-or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture. Cancer Res 49:4963-4967 (Pubitemid 19239326)
19. Mali M, Elenius K, Miettinen HM, Jalkanen M. 1993. Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J Biol Chem 268:24215-24222 (Pubitemid 23335407)
20. Mattila MM, Ruohola JK, Valve EM, Tasanen MJ, Seppanen JA, Harkonen PL. 2001. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 20:2791-2804 (Pubitemid 32549836)
21. Moscatelli D, Devesly P. 1990. Turnover of functional basic fibroblast growth factor receptors on the surface of BHK and NIH 3T3 cells. Growth Factors 3:25-33 (Pubitemid 20265012)
22. Mundhenke C, Meyer K, Drew S, Friedl A. 2002. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 160:185-194 (Pubitemid 34052279)
23. Noguchi S, Nishizawa Y, Nakamura N, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K. 1987. Growth-stimulating effect of pharmacological doses of estrogen on androgendependent Shionogi carcinoma 115 in vivo but not in cell culture. Cancer Res 47:263-268 (Pubitemid 17002133)
24. Omukai Y, Nakamura N, Hiraoka D, Nishizawa Y, Uchida N, Noguchi S, Sato B, Matsumoto K. 1987. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgenresponsive Shionogi carcinoma 115 in vivo in mice and in cell culture. Cancer Res 47:4329-4334 (Pubitemid 17124315)
25. Ornitz DM. 2000. FGFs, heparan sulfate and FGFRs: Complex interactions essential for development. Bioessays 22:108-112 (Pubitemid 30092077)
26. Steinfeld R, Van Den Berghe H, David G. 1996. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 133:405-416 (Pubitemid 26132538)
27. Szebenyi G, Fallon JF. 1999. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185:45-106 (Pubitemid 129751072)
28. Valve EM, Tasanen MJ, Ruohola JK, Harkonen PL. 1998 Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus. Biochem Biophys Res Commun 250:805-808
29. Valve EM, Ruohola JK, Tasanen MJ, Glover JF, Darbre PD, Harkonen PL. 2001. Expression of the androgen-dependent MMTV-specific orf gene in Shionogi 115 mouse mammary tumor cells. J Steroid Biochem Mol Biol 78:389-400 (Pubitemid 34014821)
30. Viklund L, Loo BM, Hermonen J, El-Darwish K, Jalkanen M, Salmivirta M. 2002. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein. Biochem Biophys Res Commun 290:146-152 (Pubitemid 34694476)
31. Wiksten JP, Lundin J, Nordling S, Kokkola A, Haglund C. 2000. A prognostic value of syndecan-1 in gastric cancer. Anticancer Res 20:4905-4907 (Pubitemid 32319051)
32. Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. 2001. Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95:1-6
33. Woods A, Couchman JR. 1998. Syndecans:Synergistic activators of cell adhesion. Trends Cell Biol 8:189-192
34. Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L. 2003. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 55:20-29. (Pubitemid 36397741)